Related Experiment Video
Updated: Oct 13, 2025

Promoter Capture Hi-C: High-resolution, Genome-wide Profiling of Promoter Interactions
Published on: June 28, 2018
A recurrent chromosomal inversion suffices for driving escape from oncogene-induced senescence via subTAD
Christos P Zampetidis1, Panagiotis Galanos2, Andriani Angelopoulou1
1Molecular Carcinogenesis Group, Department of Histology and Embryology, Faculty of Medicine, National Kapodistrian University of Athens, 11527 Athens, Greece.
Abstract:
Oncogene-induced senescence (OIS) is an inherent and important tumor suppressor mechanism. However, if not removed timely via immune surveillance, senescent cells also have detrimental effects. Although this has mostly been attributed to the senescence-associated secretory phenotype (SASP) of these cells, we recently proposed that "escape" from the senescent state is another unfavorable outcome. The mechanism underlying this phenomenon remains elusive. Here, we exploit genomic and functional data from a prototypical human epithelial cell model carrying an inducible CDC6 oncogene to identify an early-acquired recurrent chromosomal inversion that harbors a locus encoding the circadian transcription factor BHLHE40. This inversion alone suffices for BHLHE40 activation upon CDC6 induction and driving cell cycle re-entry of senescent cells, and malignant transformation. Ectopic overexpression of BHLHE40 prevented induction of CDC6-triggered senescence. We provide strong evidence in support of replication stress-induced genomic instability being a causative factor underlying "escape" from oncogene-induced senescence.
Insights
Oncogene-induced senescence (OIS) can be escaped by senescent cells, leading to malignant transformation. A chromosomal inversion activating BHLHE40 drives this escape via replication stress.
Area of Science:
- Cellular senescence
- Tumor suppression
- Genomic instability
Background:
- Oncogene-induced senescence (OIS) is a crucial tumor suppressor mechanism.
- Senescent cells, if not cleared, can promote detrimental effects, including malignant transformation.
- The "escape" from senescence, distinct from the senescence-associated secretory phenotype (SASP), is an understudied unfavorable outcome.
Purpose of the Study:
- To elucidate the molecular mechanisms underlying "escape" from oncogene-induced senescence.
- To identify genetic alterations driving cell cycle re-entry and malignant transformation of senescent cells.
Main Methods:
- Utilized a human epithelial cell model with an inducible CDC6 oncogene.
- Analyzed genomic and functional data to identify chromosomal aberrations.
- Investigated the role of the circadian transcription factor BHLHE40 in senescence escape.
Main Results:
- Identified an early-acquired, recurrent chromosomal inversion upon CDC6 induction.
- This inversion activates the BHLHE40 locus, driving cell cycle re-entry and malignant transformation.
- Ectopic BHLHE40 expression inhibited CDC6-induced senescence; replication stress-induced genomic instability underlies senescence escape.
Conclusions:
- A specific chromosomal inversion activating BHLHE40 is a key driver of "escape" from OIS.
- Replication stress-induced genomic instability is implicated in the mechanism of senescence escape.
- Understanding this escape pathway is critical for cancer prevention and therapy.
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Non-LTR Retrotransposons
Inheritance of Chromatin Structures
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...
Gene Conversion

